Baseline Mismatch Negativity Amplitude Predicts Direction and Magnitude of Ketamine Effect in Healthy Volunteers: A Disordinal Effect
Year: 2026
Type: article
Source: Biological Psychiatry
Authors: Marco Cecchi, Jason Johannesen, Brandon J. Farley, Michael C. Quirk, Mahdi Mahmoud-Zadeh, Jason M. Uslaner, Ryan Terry-Lorenzo, Daniel G. Smith, David A. Ruhl, Michael Rotte, Austin L. Reese, Patricio O’Donnell, Jennifer E. Mollon, Christopher Missling, Yasuji Matsuoka, Michael J. Marino, Susi Lee, Igor O. Korolev, Daniel Klamer, Anna Jeong, Sokichi Honda, K.C. Fadem, Jim Doherty, Elan A. Cohen, Soren Christensen, Heramb Chadchankar, Derek L. Buhl, Megumi Adachi, Deepak C. D’Souza, Holly K. Hamilton, Mohini Ranganathan, Brian J. Roach, Larry Ereshefsky, David P. Walling, William Z. Potter, Daniel C. Javitt, Daniel H. Mathalon
Institutions: Sage Therapeutics (United States), Neurocrine Biosciences (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), Alkermes (United States), Alto Neuroscience (United States), AbbVie (Germany), Anavex Life Sciences Corp. (United States), AbbVie (United States), Lundbeck (Denmark), Yale University, VA Connecticut Healthcare System, University of Minnesota, Minneapolis VA Health Care System, Northern California Institute for Research and Education, The University of Texas at San Antonio Health Science Center, Columbia University, University of California, San Francisco, San Francisco VA Health Care System
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4415110833